| A role for estrogen in schizophrenia: clinical and preclinical findings A Gogos, AM Sbisa, J Sun, A Gibbons, M Udawela, B Dean International journal of endocrinology 2015, 2015 | 226 | 2015 |
| Autophagy has a key role in the pathophysiology of schizophrenia A Merenlender-Wagner, A Malishkevich, Z Shemer, M Udawela, ... Molecular psychiatry 20 (1), 126-132, 2015 | 204 | 2015 |
| Regionally-specific changes in levels of tumour necrosis factor in the dorsolateral prefrontal cortex obtained postmortem from subjects with major depressive disorder B Dean, N Tawadros, E Scarr, AS Gibbons Journal of affective disorders 120 (1-3), 245-248, 2010 | 130 | 2010 |
| Cholinergic connectivity: it's implications for psychiatric disorders E Scarr, AS Gibbons, J Neo, M Udawela, B Dean Frontiers in cellular neuroscience 7, 55, 2013 | 128 | 2013 |
| Different changes in cortical tumor necrosis factor-α-related pathways in schizophrenia and mood disorders B Dean, AS Gibbons, N Tawadros, L Brooks, IP Everall, E Scarr Molecular psychiatry 18 (7), 767-773, 2013 | 114 | 2013 |
| Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders GM Parkin, M Udawela, A Gibbons, B Dean World journal of psychiatry 8 (2), 51, 2018 | 107 | 2018 |
| Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects AS Gibbons, E Scarr, C McLean, S Sundram, B Dean Journal of affective disorders 116 (3), 184-191, 2009 | 105 | 2009 |
| Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue CY Lai, SY Lee, E Scarr, YH Yu, YT Lin, CM Liu, TJ Hwang, MH Hsieh, ... Translational psychiatry 6 (1), e717-e717, 2016 | 72 | 2016 |
| Widespread decreases in cortical muscarinic receptors in a subset of people with schizophrenia AS Gibbons, E Scarr, S Boer, T Money, WJ Jeon, C Felder, B Dean International Journal of Neuropsychopharmacology 16 (1), 37-46, 2013 | 66 | 2013 |
| Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targeting microRNA E Scarr, JM Craig, MJ Cairns, MS Seo, JC Galati, NJ Beveridge, ... Translational psychiatry 3 (2), e230-e230, 2013 | 65 | 2013 |
| Recent advances in postmortem pathology and neurochemistry in schizophrenia B Dean, S Boer, A Gibbons, T Money, E Scarr Current opinion in psychiatry 22 (2), 154-160, 2009 | 63 | 2009 |
| Non-coding RNA as novel players in the pathophysiology of schizophrenia A Gibbons, M Udawela, B Dean Non-coding RNA 4 (2), 11, 2018 | 61 | 2018 |
| The cholinergic system: an emerging drug target for schizophrenia A Gibbons, B Dean Current pharmaceutical design 22 (14), 2124-2133, 2016 | 53 | 2016 |
| Changes in cortical N-methyl-d-aspartate receptors and post-synaptic density protein 95 in schizophrenia, mood disorders and suicide B Dean, AS Gibbons, S Boer, A Uezato, J Meador-Woodruff, E Scarr, ... Australian & New Zealand Journal of Psychiatry 50 (3), 275-283, 2016 | 50 | 2016 |
| Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis G Chana, CA Bousman, TT Money, A Gibbons, P Gillett, B Dean, ... Frontiers in cellular neuroscience 7, 95, 2013 | 47 | 2013 |
| AMPA receptor expression is increased post-mortem samples of the anterior cingulate from subjects with major depressive disorder AS Gibbons, L Brooks, E Scarr, B Dean Journal of affective disorders 136 (3), 1232-1237, 2012 | 45 | 2012 |
| The role of muscarinic receptors in the pathophysiology of mood disorders: a potential noveltreatment? W Je Jeon, B Dean, E Scarr, A Gibbons Current neuropharmacology 13 (6), 739-749, 2015 | 39 | 2015 |
| Lower [3H] LY341495 binding to mGlu2/3 receptors in the anterior cingulate of subjects with major depressive disorder but not bipolar disorder or schizophrenia CE McOmish, G Pavey, A Gibbons, S Hopper, M Udawela, E Scarr, ... Journal of affective disorders 190, 241-248, 2016 | 38 | 2016 |
| Treating schizophrenia: novel targets for the cholinergic system TT Money, E Scarr, M Udawela, AS Gibbons, WJ Jeon, MS Seo, B Dean CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2010 | 33 | 2010 |
| The neurobiology of APOE in schizophrenia and mood disorders AS Gibbons, M Udawela, WJ Jeon, MS Seo, L Brooks, B Dean Front Biosci 16, 962-979, 2011 | 31 | 2011 |
